A phase II study of 17-N-Allylamino-17-demethoxy Geldanamycin (17-AAG)in metastatic renal cell carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tanespimycin (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 24 Jun 2013 Biomarkers information updated
- 23 Aug 2005 New trial record.